Becton Dickinson & Co (BDX) - צמיחת רווח נקי למניה אחת לשנה הנוכחית
Becton Dickinson & Co (BDX) outsources electronics assembly and freight delivery to third-party contractors. Annual earnings per share growth demonstrates a yield trend where the parameter has stabilized at 4.40. Stable demand for medical supplies provides the company with high crisis resilience. The business is currently scaling its global portfolio by developing intelligent injection systems and laboratory research automation.
%20%D7%A6%D7%9E%D7%99%D7%97%D7%AA%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%91%D7%A9%D7%A0%D7%94%20%D7%94%D7%A0%D7%95%D7%9B%D7%97%D7%99%D7%AA&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_BDX_-_Becton-Dickinson--Co_-_Earnings-per-share-growth-in-current-year "גידול ברווח למניה בשנה הנוכחית BD (BDX): לתקופה 04.07.2022 - 14.11.2026 | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור Becton Dickinson & Company (BDX)
Becton Dickinson & Co (BDX) maintains stable pricing power within the medical consumables segment, allowing the company to index prices, which directly impacts net profit dynamics. The measured YoY EPS growth quantifies the annual change in earnings per share, enabling investors to assess the smoothness of the yield recovery and the efficiency of operational management amid strict clinic budget controls.
